Newly-released figures show a staggering 110 out of 111 NHS trusts that have specialist ophthalmology units in the UK failed ...
European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results